The Biological Rationale

Metabolic Reprogramming as a Hallmark of Cancer

Tumors adapt their metabolism to:
• Sustain high biosynthetic output
• Maintain redox homeostasis under hypoxia
• Resist therapeutic stress
• Promote microenvironmental survival

Upregulation of nutrient transporters is a central feature of this reprogramming. Elevated transporter expression correlates with:
• Aggressive tumor phenotypes
• Therapy resistance
• Poor clinical outcomes in multiple solid tumor subtypes
This creates a selective vulnerability.